Aznar J - Search Results

1

Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone.

Réganon E, Ferrando F, Vila V, Villa P, Martínez-Sales V, Fayos L, Ruano M, Aznar J. Réganon E, et al. Among authors: aznar j. Haemostasis. 1998 Mar-Apr;28(2):99-105. doi: 10.1159/000022419. Haemostasis. 1998. PMID: 10087435 Clinical Trial.

2

Hypercoagulable state after thrombolytic therapy in patients with acute myocardial infarction (AMI) treated with streptokinase.

Vila V, Regañón E, Aznar J, Lacueva V, Ruano M, Laiz B. Vila V, et al. Among authors: aznar j. Thromb Res. 1990 Mar 1;57(5):783-94. doi: 10.1016/0049-3848(90)90035-b. Thromb Res. 1990. PMID: 2339369

3

Human fibrinogen heterogeneity. A study of limited fibrinogen degradation.

Regañón E, Vila V, Aznar J, Laiz B. Regañón E, et al. Among authors: aznar j. Clin Chim Acta. 1989 Sep 15;184(1):7-17. doi: 10.1016/0009-8981(89)90252-0. Clin Chim Acta. 1989. PMID: 2532081

4

Unstimulated and thrombin-stimulated platelets binding to immobilized fibrinogen and fibrin on polystyrene supports.

Martínez-Sales V, Vila V, Réganon E, Aznar J. Martínez-Sales V, et al. Among authors: aznar j. Haemostasis. 1995 Jul-Aug;25(4):158-65. doi: 10.1159/000217156. Haemostasis. 1995. PMID: 7557654

5

Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.

Reganon E, Vila V, Aznar J, Lacueva V, Martinez V, Ruano M. Reganon E, et al. Among authors: aznar j. Thromb Haemost. 1993 Dec 20;70(6):978-83. Thromb Haemost. 1993. PMID: 8165621 Clinical Trial.

6

Decreased high-molecular weight fibrinogen and impaired alpha-chain polymerization in full-term newborns.

Réganon E, Vila V, Laiz B, Gilabert J, Aznar J. Réganon E, et al. Among authors: aznar j. Haemostasis. 1993 May-Jun;23(3):149-58. doi: 10.1159/000216868. Haemostasis. 1993. PMID: 8276318

7

Platelet function in patients with chronic coronary heart disease on long-term anticoagulant therapy: effect of anticoagulant stopping.

Vallés J, Aznar J, Santos T, Villa P, Fernández A. Vallés J, et al. Among authors: aznar j. Haemostasis. 1993 Jul-Aug;23(4):212-8. doi: 10.1159/000216877. Haemostasis. 1993. PMID: 8314171 Clinical Trial.

8

Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study.

Martínez-Sales V, Vila V, Réganon E, Goberna MA, Ferrando F, Palencia MA, Aznar J. Martínez-Sales V, et al. Among authors: aznar j. Haemostasis. 1998 Nov-Dec;28(6):301-6. doi: 10.1159/000022446. Haemostasis. 1998. PMID: 10461012 Clinical Trial.

9

Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis.

Villa P, Aznar J, Vaya A, España F, Ferrando F, Mira Y, Estellés A. Villa P, et al. Among authors: aznar j. Thromb Haemost. 1999 Sep;82(3):1011-4. Thromb Haemost. 1999. PMID: 10494755

10

Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction.

Reganon E, Vila V, Ferrando F, Martínez-Sales V, Fayos L, Ruano M, Aznar J. Reganon E, et al. Among authors: aznar j. Thromb Haemost. 1999 Nov;82(5):1403-5. Thromb Haemost. 1999. PMID: 10595627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

628 results

Search Page

Filters